Molecular Profiling of Malignant Pleural Effusion in Metastatic Non-Small Cell Lung Carcinoma

被引：0
|
作者：
Carter, Jamal H. [1 ]
Miller, James A. [1 ]
Maleki, Zahra [1 ]
机构：
[1] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA
来源：
MODERN PATHOLOGY | 2016年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
366
引用
收藏
页码：94A / 94A
页数：1
相关论文
共 50 条
  • [1] Molecular Profiling of Malignant Pleural Effusion in Metastatic Non-Small Cell Lung Carcinoma
    Carter, Jamal H.
    Miller, James A.
    Maleki, Zahra
    [J]. LABORATORY INVESTIGATION, 2016, 96 : 94A - 94A
  • [2] Molecular Profiling of Malignant Pleural Effusion in Metastatic Non-Small-Cell Lung Carcinoma The Effect of Preanalytical Factors
    Carter, Jamal
    Miller, James Adam
    Feller-Kopman, David
    Ettinger, David
    Sidransky, David
    Maleki, Zahra
    [J]. ANNALS OF THE AMERICAN THORACIC SOCIETY, 2017, 14 (07) : 1169 - 1176
  • [3] MOLECULAR TESTING AND CYTOPATHOLOGIC FEATURES OF MALIGNANT PLEURAL EFFUSION IN PATIENTS WITH NON-SMALL CELL LUNG CANCER
    Fujii, T.
    Fukawa, T.
    Kishi, K.
    Ohashi, K.
    [J]. ACTA CYTOLOGICA, 2010, 54 (03) : 414 - 414
  • [4] Non-small cell lung carcinoma metastatic cells in a pericardial effusion
    Gerard, D.
    Thomas, B.
    Lesesve, J. -F.
    [J]. CYTOPATHOLOGY, 2018, 29 (03) : 311 - 312
  • [5] Application of malignant pleural effusion cell blocks in the diagnosis and personalized treatment of advanced non-small cell lung carcinoma
    Wei Luan
    Nier Cha
    Yinzai He
    Baoqing Jia
    [J]. Oncology and Translational Medicine, 2019, 5 (03) : 109 - 113
  • [6] The therapeutic efficacy of osimertinib in non-small cell lung cancer with malignant pleural effusion
    Nagamine, Hiroaki
    Sawa, Kenji
    Kaneda, Hiroyasu
    Ogawa, Koichi
    Nakahama, Kenji
    Matsumoto, Yoshiya
    Tani, Yoko
    Mitsuoka, Shigeki
    Kimura, Tatsuo
    Kawaguchi, Tomoya
    [J]. ANNALS OF ONCOLOGY, 2022, 33 : S523 - S523
  • [7] Role of molecular testing for malignant pleural effusion in targeted therapy for advanced non-small cell lung cancer
    Lin, Rixu
    Li, Yida
    Lin, Yi
    Tian, Wenyi
    Jiang, Lei
    Li, Jianmin
    [J]. DIAGNOSTIC CYTOPATHOLOGY, 2023, 51 (07) : 397 - 405
  • [8] Angiogenetic biomarkers in non-small cell lung cancer with malignant pleural effusion: Correlations with patient survival and pleural effusion control
    Hsu, I-Lin
    Su, Wu-Chou
    Yan, Jing-Jou
    Chang, Jia-Ming
    Lai, Wu-Wei
    [J]. LUNG CANCER, 2009, 65 (03) : 371 - 376
  • [9] EGFR mutations in malignant pleural effusion of non-small cell lung cancer:: A case report
    Huang, MJ
    Lim, KH
    Tzen, CY
    Hsu, HS
    Yen, Y
    Huang, BS
    [J]. LUNG CANCER, 2005, 49 (03) : 413 - 415
  • [10] Permanent pleural catheter (PPC) for malignant pleural effusion (PE) in advanced non-small cell lung cancer (NSCLC)
    Martinez Kareaga, M.
    Urbieta-Macazaga, N.
    Sanchez-Vieco, C.
    Tomas-Lopez, L.
    Intxaurbe-Etxebarria, I.
    Mareque, B.
    Torrego, N.
    Narro, A.
    Punti, L.
    Guillen, I.
    [J]. ANNALS OF ONCOLOGY, 2019, 30 : 63 - 63
12345